Ian Karp | Senior Vice President , Investor Relations and Corporate Communications |
John Leonard | President and Chief Executive Officer |
David Lebwohl | Executive Vice President and Chief Medical Officer |
Laura Sepp-Lorenzino | Executive Vice President and Chief Scientific Officer |
Glenn Goddard | Executive Vice President and Chief Financial Officer |
Mary Kate Davis | Bank of America |
Joseph Thome | Cowen and Company |
Brian Cheng | J.P. Morgan |
Richard Law | Credit Suisse |
Swapnil Malekar | Piper Sandler |
Dae Gon Ha | Stifel |
Terence Flynn | organ Stanley |
Maury Raycroft | Jefferies |
Jay Olson | Oppenheimer & Co. |
Luca Issi | RBC Capital Markets |
Joon Lee | Truist Securities |
Good morning. And welcome to the Intellia Therapeutics' Third Quarter 2022 Financial Results Conference Call. My name is Andrew and I will be your conference operator today.
Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the company's request and will be available at the company's website following the end of the call.